LU82013A1 - Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation - Google Patents

Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation Download PDF

Info

Publication number
LU82013A1
LU82013A1 LU82013A LU82013A LU82013A1 LU 82013 A1 LU82013 A1 LU 82013A1 LU 82013 A LU82013 A LU 82013A LU 82013 A LU82013 A LU 82013A LU 82013 A1 LU82013 A1 LU 82013A1
Authority
LU
Luxembourg
Prior art keywords
thiazolidine
carboxylic acid
pharmaceutically acceptable
pharmaceutical composition
acceptable salt
Prior art date
Application number
LU82013A
Other languages
English (en)
French (fr)
Inventor
M Gosalvez
Original Assignee
M Gosalvez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M Gosalvez filed Critical M Gosalvez
Publication of LU82013A1 publication Critical patent/LU82013A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
LU82013A 1978-12-21 1979-12-19 Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation LU82013A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/971,729 US4384001A (en) 1978-12-21 1978-12-21 Treatment of tumors with thiazolidine-4-carboxylic acid
US97172978 1978-12-21

Publications (1)

Publication Number Publication Date
LU82013A1 true LU82013A1 (fr) 1981-02-03

Family

ID=25518727

Family Applications (1)

Application Number Title Priority Date Filing Date
LU82013A LU82013A1 (fr) 1978-12-21 1979-12-19 Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation

Country Status (16)

Country Link
US (1) US4384001A (it)
JP (1) JPS55115822A (it)
AU (1) AU5390579A (it)
BE (1) BE880744A (it)
CA (1) CA1149284A (it)
DE (1) DE2951050A1 (it)
DK (1) DK542979A (it)
ES (1) ES487052A0 (it)
FR (1) FR2444459A1 (it)
GB (1) GB2039736B (it)
IL (1) IL58948A0 (it)
IT (1) IT1193348B (it)
LU (1) LU82013A1 (it)
NL (1) NL7909199A (it)
SE (1) SE7910300L (it)
ZA (1) ZA796918B (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE53332B1 (en) * 1980-03-14 1988-10-26 Efamol Ltd Pharmaceutical compositions
JPS57128625A (en) * 1981-01-30 1982-08-10 Rikagaku Kenkyusho Carcinostatic
US4335210A (en) * 1981-02-11 1982-06-15 Cornell Research Foundation Method of producing L-cysteine
FR2547729B1 (fr) * 1983-06-24 1986-05-02 Riker Laboratories Inc Medicament a base d'acide dl thiazolidine carboxylique
FR2547728B1 (fr) * 1983-06-24 1986-05-02 Riker Laboratories Inc Medicament a base d'acide d thiazolidine carboxylique
JPS62501769A (ja) * 1984-12-18 1987-07-16 デイビツト ラビン 細胞毒性アルデヒドとベニシラミンとの反応性成物を含有する抗腫瘍組成物及びその使用方法
JPH066578B2 (ja) * 1985-12-27 1994-01-26 三共株式会社 チアゾリジン誘導体
JPH01170063U (it) * 1988-05-11 1989-11-30
JPH0467539U (it) * 1990-10-18 1992-06-16
DE69214467T3 (de) * 1991-01-10 2000-09-28 Transcend Therapeutics, Inc. Verwendung von L-2-oxo Thiazolidin-4-carboxylat zur Behandlung von Atemnotsyndrom
ES2277787B1 (es) * 2006-01-02 2008-06-16 Universidad De Cadiz Empleo de tioprolina en tratamientos de reduccion de peso corporal.

Also Published As

Publication number Publication date
IT7928170A0 (it) 1979-12-18
CA1149284A (en) 1983-07-05
FR2444459B1 (it) 1983-04-01
BE880744A (fr) 1980-06-19
JPS55115822A (en) 1980-09-06
JPS6328045B2 (it) 1988-06-07
US4384001A (en) 1983-05-17
DE2951050A1 (de) 1980-07-10
ZA796918B (en) 1980-11-26
GB2039736B (en) 1983-04-13
FR2444459A1 (fr) 1980-07-18
IL58948A0 (en) 1980-03-31
AU5390579A (en) 1980-06-26
IT1193348B (it) 1988-06-15
DK542979A (da) 1980-06-22
ES8102108A1 (es) 1980-12-16
SE7910300L (sv) 1980-06-22
ES487052A0 (es) 1980-12-16
NL7909199A (nl) 1980-06-24
GB2039736A (en) 1980-08-20

Similar Documents

Publication Publication Date Title
JP6837486B2 (ja) 加齢に関連する認知障害及び神経炎症を予防及び/又は治療する方法
US20230128449A1 (en) Silicate containing compositions and methods of treatment
LU82013A1 (fr) Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation
JP5086331B2 (ja) 細菌性疾患、ウィルス性疾患、真菌症、炎症、及び疼痛の治療用組成物
EP1267881B1 (fr) UTILISATION DE MnTBAP DANS LE TRAITEMENT D'INSUFFISANCES HEPATOCELLULAIRES
JPH03163026A (ja) 血管拡張剤
FR2536995A1 (fr) Composition pour le traitement de l'arthrite
EP3624822B1 (fr) Principe actif constitue par un melange de composes poly-lysine et utilisation dans la prevention des avc et le traitement de la phase inflammatoire post-avc
CA1277240C (fr) Medicament modulateur de l'immunite et son procede de preparation
EP1061938B1 (en) Oral compositions at low dosage of cytotoxic proteins
WO2021074284A1 (fr) Utilisation de nictotinamide mononucléotide (nmn) pour la prevention et/ou le traitement de la polyarthrite rhumatoïde et compositions correspondantes
EP1967187B1 (fr) Composition à base de rutine et de L-lysine
EP0152366A2 (fr) Compositions à usage thérapeutique comprenant des composés organo-siliciés
TWI722492B (zh) 含蓮蓬萃取物之組合物及其用於治療頭頸癌症之用途
JP2009084211A (ja) 神経細胞賦活組成物
FR2683455A1 (fr) Composition pour la stimulation de la synthese localisee des tissus conjonctifs.
FR2779063A1 (fr) Compositions a base de pentoxifylline et leur utilisation therapeutique
WO2000024402A1 (fr) Utilisation d'antifongiques dans le traitement des scleroses
WO2021105461A1 (fr) Utilisation de composés pour la prévention et/ou le traitement de la spondylarthrite ankylosante et compositions correspondantes
FR2693208A1 (fr) Procédé d'obtention d'une composition enzymatique d'origine végétale ainsi que composition obtenue par la mise en Óoeuvre de ce procédé.
JPS61180722A (ja) ペプチド‐および/またはアミノ酸含有治療薬
FR2857594A1 (fr) Composition pharmaceutique pour l'administration par voie nasale de piribedil
FR2684297A1 (fr) Utilisation d'un acide amine soufre pour la preparation d'un medicament destine au traitement de l'eczema.
JPWO2006132245A1 (ja) 腫瘍増殖抑制剤
JP2004168767A (ja) α−グルコシダーゼ阻害剤